IBCSG Circular Letter
Volume 24 Issue 2
Race for Life - Fighting with Power against Cancer
Race for Life is a charity bike marathon and a solidarity festival for the benefit of cancer patients in Switzerland. IBCSG is one of the partner organisations and will again participate in the race with a motivated Team.
Thank you for your support: https://fundraise.raceforlife.ch/projects/ibcsg-women-4-women-279
Article on the long-term results from the SOFT and TEXT Trial in the ASCO Post
Schweizer Frauenlauf Bern:
On Sunday June 10, 2018, IBCSG women and their families and friends participate in the 5km walk at the Schweizer Frauenlauf held in Bern every year.
They walk together for young women with breast cancer to demonstrate to young patients who face a variety of unique medical and psychosocial issues because of their diagnosis and treatment, they are not alone. Infertility, premature menopause and sexual dysfunction following treatment are of deep concern for these young patients and may contribute to the greater distress observed in this population. They walk together to demonstrate that IBCSG is committed to the research Program for Young Patients with breast cancer (PYP). As a Charity Partner of Frauenlauf Bern IBCSG has a booth at the Waisenhausplatz in Berne.
TEXT & SOFT Press Release ASCO 2018
Ovarian Suppression Reduces Recurrence and Can Improve Survival in Young Breast Cancer Patients
SOFT TEXT PRESS RELEASE 2018 June.pdf
363. Francis PA, Pagani O, Fleming GF, Walley BA, Colleoni M, Láng I, Gómez HL, Tondini C, Ciruelos E, Burstein HJ, Bonnefoi HR, Bellet M, Martino S, Geyer Jr. CE, Goetz MP, Stearns V, Pinotti G, Puglisi F, Spazzapan S, Climent MA, Pavesi L, Ruhstaller T, Davidson NE, Coleman R, Debled M, Buchholz S, Ingle JN, Winer EP, Maibach R, Rabaglio‑Poretti M, Ruepp B, Di Leo A, Coates AS, Gelber RD, Goldhirsch A, Regan MM, the SOFT and TEXT Investigators and the International Breast Cancer Study Group. Tailoring adjuvant endocrine therapy for premenopausal breast cancer. N Engl J Med. doi: 10.1056/NEJMoa1803164. 2018 June 4. [Epub ahead of print] (IBCSG 24-02, 25-02) (Journal Impact Factor 72.406).
362. Zeidan YH, Habib JG, Ameye L, Paesmans M, de Azambuja E, Gelber RD, Campbell I, Nordenskjöld B, Gutiérez J, Anderson M, Lluch A, Gnant M, Goldhirsch A, Di Leo A, Joseph DJ, Crown J, Piccart-Gebhart M, Francis PA. Postmastectomy radiation therapy in women with T1-T2 tumors and 1 to 3 positive lymph nodes: Analysis of the Breast International Group 02-98 Trial. Int J Radiat Oncol Biol Phys 2018 Jun 1:101(2):316-324. doi: 10.1016/j.ijrobp.2018.01.105. Epub 2018 February 6. (IBCSG 20-98) (Journal Impact Factor 5.133).
361. Dowsett M, Sestak I, Regan MM, Dodson A, Viale G, Thürlmann B, Colleoni M, Cuzick J. Integration of clinical variables for the prediction of late distant recurrence in patients with oestrogen receptor positive breast cancer treated with 5 years of endocrine therapy: CTS5. J Clin Oncol. doi: 10.1200/JCO.2017.76.4258. 2018 April 20. [Epub ahead of print] (BIG 1-98) (Journal Impact Factor 24.08).
360. Munzone E, Gray KP, Fumagalli C, Guerini-Rocco E, Láng I, Ruhstaller T, Gianni L, Kammler R, Viale G, Di Leo A, Coates AS, Gelber RD, Regan MM, Goldhirsch A, Barberis M, Colleoni M. Mutational analysis of triple-negative breast cancers within the International Breast Cancer Study Group (IBCSG) Trial 22-00. Breast Cancer Res Treat. doi: 10.1007/s10549-018-4767-1. Epud 2018 March 27. [Epub ahead of print] (IBCSG 22-00).
The paper and is attached and linked here: